We have also very recently revealed that Pim kinases are involved downstream of STAT5 in enhancing mTORC1/MCL-1 pathway in FLT3-ITD-expressing AML cells to confer these cells resistance to PI3K/Akt inhibitors [39]. This evidence concerns the gene MCL1 and acute myeloid leukemia.